Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Harmonization Task Force Moves Into “Implementation Mode”

This article was originally published in The Gray Sheet

Executive Summary

Efforts to harmonize device regulations globally will see more activity over the next year if Larry Kessler has his way

You may also be interested in...



FDA Wants To Know It Can Trust Third-Party Auditors, Reports

Before FDA signs on to a harmonized, global system of medical device regulation, it must know it can trust the information it gets from outside regulators and auditors, agency officials say

FDA Wants To Know It Can Trust Third-Party Auditors, Reports

Before FDA signs on to a harmonized, global system of medical device regulation, it must know it can trust the information it gets from outside regulators and auditors, agency officials say

FDA Asks For Industry Input On 2008 Guidance Priorities

FDA is asking manufacturers to help the agency prioritize within a 1list of 81 CDRH guidance documents it is considering developing in 2008

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel